Biotech

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ptc Therapeutics Inc. (NASDAQ:PTCT) reported that Complete Pharma Holdings Ii, Llc. has picked up 6,683,598 of common stock as of 2017-04-27. The acquisition brings the aggregate amount owned by Complete Pharma Holdings Ii, Llc. to a...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Oncomed Pharmaceuticals Inc (NASDAQ:OMED) reported that Biotechnology Value Fund L P has picked up 1,372,923 of common stock as of 2017-04-27. The acquisition brings the aggregate amount owned byBiotechnology Value Fund L P to a total...

NanoViricides Inc (NYSEMKT:NNVC) shares dipped 2.61% on Wednesday to $1.12 and were unchanged in after-hours trading. Share prices have been trading in a 52-week range of $1.03 to $2.18. The company has a market cap of $72.89 million at 62.82 million shares outstanding. NanoViricides Inc is a nano-biopharmaceutical company with several drugs...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Audentes Therapeutics Inc. (NASDAQ:BOLD) reported that Flynn James E  has picked up 1,214,423 of common stock as of 2017-04-26. The acquisition brings the aggregate amount owned by Flynn James E to a total of 1,214,423...

In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Edge Therapeutics Inc. (NASDAQ:EDGE) reported that Satter Muneer A. has picked up 1,800,000 of common stock as of 2017-04-25. The acquisition brings the aggregate amount owned by Satter Muneer A. to a total of 1,800,000...